Welcome to our dedicated page for Vendome Acquisition I SEC filings (Ticker: VNME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vendome Acquisition I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vendome Acquisition I's regulatory disclosures and financial reporting.
Meteora Capital, LLC filed a Schedule 13G disclosing beneficial ownership of 1,999,794 shares of Vendome Acquisition Corp I Class A common stock, equal to 9.99% of the class. All shares are held in funds and managed accounts for which Meteora Capital serves as investment manager.
The filing attributes the holdings to Meteora-managed vehicles, with shared voting and dispositive power over all reported shares and no sole power. Managing Member Vik Mittal is listed as a reporting person. The securities are described as acquired and held in the ordinary course of business, not for changing or influencing control of Vendome.
Barclays PLC filed an amended Schedule 13G reporting its beneficial ownership in Vendome Acquisition Corp-A common stock. Barclays reports beneficial ownership of 450 shares, representing 0.00% of the class. Barclays has sole voting and dispositive power over these 450 shares and no shared power.
The filing confirms that the holdings are below 5% of the outstanding common stock and are held in the ordinary course of business, not for the purpose of changing or influencing control of Vendome Acquisition Corp-A.
Vendome Acquisition Corporation I (VNME) filed its quarterly report as a newly formed SPAC after completing its July Initial Public Offering of 20,000,000 units at $10.00 each, raising $200,000,000 plus $2,648,000 from private placement warrants.
As of September 30, 2025, the company reported total assets of $202,785,616, including $202,068,698 of cash held in a trust account and $399,771 of cash outside the trust. Net income for the three months ended September 30, 2025 was $1,820,558, driven by $2,068,698 of interest income on trust investments and $248,140 of formation and operating expenses.
All 20,000,000 Class A ordinary shares are redeemable at approximately $10.10 per share, and 5,000,000 Class B founder shares remain outstanding. Vendome has 24 months from the IPO closing to complete a business combination, with working capital supported by funds outside the trust and potential sponsor-backed working capital loans and a convertible note of up to $840,000.